Drugmakers Plan 2026 U.S. Price Increases on Over 350 Branded Medications Despite Political Pressure 
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube 
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle 
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market 
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts 
Google Accelerates AI Infrastructure With Ironwood TPU Expansion in 2026 
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China 
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch 
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies 
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round 
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration 
Neuralink Plans High-Volume Brain Implant Production and Fully Automated Surgery by 2026 
Boeing Secures Major $2.7 Billion U.S. Military Contract for Apache Helicopter Support 
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026 
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms 
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares 
NEW YORK, March 10, 2017 -- The following statement is being issued by Levi & Korsinsky, LLP:
To: All persons or entities who purchased or otherwise acquired American Depositary Receipts of Pearson plc (“Pearson”) (NYSE:PSO) between January 21, 2016 and January 17, 2017. You are hereby notified that Levi & Korsinsky has commenced the class action Chupka v. Pearson plc, et al. (Case No. 1:17-cv-01422) in the USDC for the Southern District of New York. To get more information go to:
http://www.zlk.com/pslra/pearson-plc
or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.
The complaint alleges that during the Class Period, the Company made materially false and/or misleading statements regarding the Company’s business, operational and compliance policies. In particular, the complaint alleges the Company made overly optimistic projections for 2017 and 2018 regarding its U.S. education business when, in reality, students were not likely to purchase the Company’s products when more affordable alternatives were available.
On January 18, 2017, Pearson issued a press release announcing that it no longer expected to achieve its operative profit guidance for 2018 as a result of “[t]he North American higher education courseware market being much weaker than expected” and that Pearson would “rebase” its dividend “from 2017 onwards.” Following this news, shares of Pearson fell approximately 29% on January 18, 2017, from a previous close of $9.99 to a close of $7.13 per share.
Take Action: if you suffered a loss in Pearson you have until April 25, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Levi & Korsinsky, LLP Joseph E. Levi, Esq. 30 Broad Street - 24th Floor New York, NY 10004 Tel: (212) 363-7500 Toll Free: (877) 363-5972 Fax: (212) 363-7171 www.zlk.com
